The DOI matches its Crossref record; 469 of the 469 references it cites were found in a registry or an index.
The serotonergic system in ageing and Alzheimer's disease
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 3×
“hyperphosphorylated tau filaments (Braak and Braak, 1991; for review see Duyckaerts et al., 2009).”
Dahlstroem, A., & Fuxé, K. (1964) · PubMed · Cited by 5,133
Alzheimer's Disease Is a Synaptic Failure
Selkoe, D. J. (2002) · Science · doi:10.1126/science.1074069 · Cited by 4,420
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
A review of central 5-HT receptors and their function
Barnes, N. M., & Sharp, T. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00010-6 · Cited by 3,161
Blennow, K., de Leon, M. J., & Zetterberg, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69113-7 · Cited by 3,134
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Millan, M. J. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00009-6 · Cited by 3,035
Structure and function of the brain serotonin system
Jacobs, B. L., & Azmitia, E. C. (1992) · Physiological Reviews · doi:10.1152/physrev.1992.72.1.165 · Cited by 2,576
Steinbusch, H. W. M. (1981) · Neuroscience · doi:10.1016/0306-4522(81)90146-9 · Cited by 2,415
Mesulam, M. ‐., Mufson, E. J., Levey, A. I., & Wainer, B. H. (1983) · Journal of Comparative Neurology · doi:10.1002/cne.902140206 · Cited by 1,962
Azmitia, E. C., & Segal, M. (1978) · Journal of Comparative Neurology · doi:10.1002/cne.901790311 · Cited by 1,909
Molecular, pharmacological and functional diversity of 5-HT receptors
Hoyer, D., Hannon, J. P., & Martin, G. R. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(01)00746-8 · Cited by 1,865
Rowland, L. P., & Shneider, N. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442207 · Cited by 1,812
Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease.
Griffin, W. S., Stanley, L. C., Ling, C., White, L., MacLeod, V, Perrot, L. J., White, C. L., & Araoz, C. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7611 · Cited by 1,777
Uber eine eigenartige Erkrankung der Hirnrinde
Alzheimer, A. (1907) · Medical Entomology and Zoology · Cited by 1,503
NEUROTRANSMITTER-RELATED ENZYMES AND INDICES OF HYPOXIA IN SENILE DEMENTIA AND OTHER ABIOTROPHIES
BOWEN, D. M., SMITH, C. B., WHITE, P., & DAVISON, A. N. (1976) · Brain · doi:10.1093/brain/99.3.459 · Cited by 1,311
Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Proposals for the classification and nomenclature of functional receptors for 5-hydroxytryptamine
Bradley, P. B., Engel, G., Feniuk, W., Fozard, J. R., Humphrey, P. P. A., Middlemiss, D. N., Mylecharane, E. J., Richardson, B. P., & Saxena, P. R. (1986) · Neuropharmacology · doi:10.1016/0028-3908(86)90207-8 · Cited by 1,258
Dickerson, B. C., Bakkour, A., Salat, D. H., Feczko, E., Pacheco, J., Greve, D. N., Grodstein, F., Wright, C. I., Blacker, D., Rosas, H. D., et al. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn113 · Cited by 1,153
Classification and basic pathology of Alzheimer disease
Duyckaerts, C., Delatour, B., & Potier, M.-C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0532-1 · Cited by 1,031
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017 · cited 7×
“N,N-dimethyl-5-(1,3,5-trimethylpyrazol-4-yl)-1,2,3,4-tetrahydronaphthalen-2-amine; Ab, amyloid beta; Ab1–42, Fibrillogenic amyloid beta; AbPPswe/PS1DE9, Transgenic mouse expressing APP swedish and PS1DE9 mutations; BDNF, brain derived neurotrophic factor; BF, beaded fibres; Bmax, receptor density; BP, binding potencia…”
InfluentialAmyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease
Oddo, S. (2003) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.08.012 · Cited by 980 · cited 1×
“…with our data from studies in the 3xTg-AD mouse model of AD, which expresses Ab plaques and tau pathology in a spatio-temporal order resembling AD and exhibits pronounced deficits in cognitive function including learning and memory (Clinton et al., 2007; Frazer et al., 2008; Oddo et al., 2003a,b).”
Methods for determining numbers of cells and synapses: A case for more uniform standards of review
Coggeshall, R. E., & Lekan, H. A. (1996) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19960101)364:1<6::aid-cne2>3.0.co;2-9 · Cited by 972
Correction for partial volume effects in PET: principle and validation.
ROUSSET, O. G., Ma, Y., & Evans, A. C. (1998) · PubMed · Cited by 919
IDENTIFICATION AND ASSAY OF SEROTONIN IN BRAIN
Bogdanski, D. F., Pletscher, A., Brodie, B. B., & Udenfriend, S. (1956) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11657-1 · Cited by 861
TWO KINDS OF TRYPTAMINE RECEPTOR
GADDUM, J. H., & PICARELLI, Z. P. (1957) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1957.tb00142.x · Cited by 847
A PHA-L analysis of ascending projections of the dorsal raphe nucleus in the rat
Vertes, R. P. (1991) · Journal of Comparative Neurology · doi:10.1002/cne.903130409 · Cited by 842 · cited 7×
“…which contain the majority of 5-HT neurones, give rise to serotonergic projections that are widely distributed throughout the brain notably in areas critical for cognitive functions such as septum, frontal cortex, temporal cortex and the hippocampal formation (Vertes, 1991; Vertes et al., 1999).”
InfluentialOtt, A., Breteler, M. M. B., van Harskamp, F., Claus, J. J., van der Cammen, T. J. M., Grobbee, D. E., & Hofman, A. (1995) · BMJ · doi:10.1136/bmj.310.6985.970 · Cited by 792
Raina, P., Santaguida, P., Ismaila, A., Patterson, C., Cowan, D., Levine, M., Booker, L., & Oremus, M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-5-200803040-00009 · Cited by 771
The distribution of substance P and 5‐hydroxytryptamine in the central nervous system of the dog
Amin, A. H., Crawford, T. B. B., & Gaddum, J. H. (1954) · The Journal of Physiology · doi:10.1113/jphysiol.1954.sp005229 · Cited by 704
Wong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., Ravert, H. T., Wilson, A. A., Rosenbaum, A. E., Gjedde, A., Douglass, K. H., et al. (1984) · Science · doi:10.1126/science.6334363 · Cited by 697
Amaral, D. G., & Kurz, J. (1985) · Journal of Comparative Neurology · doi:10.1002/cne.902400104 · Cited by 687
ERSPAMER, V., & ASERO, B. (1952) · Nature · doi:10.1038/169800b0 · Cited by 670
Serotoninergic regulation of emotional and behavioural control processes
Cools, R., Roberts, A. C., & Robbins, T. W. (2008) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2007.10.011 · Cited by 656 · cited 2×
“Cortical 5-HT projections play an important role in motor functions and in shaping emotions (Cools et al., 2008; Jacobs and Fornal, 1997; Loubinoux et al., 2002).”
Two Distinct Central Serotonin Receptors with Different Physiological Functions
Peroutka, S. J., Lebovitz, R. M., & Snyder, S. H. (1981) · Science · doi:10.1126/science.7221567 · Cited by 637
Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence
Fibiger, H. C. (1991) · Trends in Neurosciences · doi:10.1016/0166-2236(91)90117-d · Cited by 599
SERUM VASOCONSTRICTOR (SEROTONIN)
Rapport, M. M., Green, A. A., & Page, I. H. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57137-4 · Cited by 552
Projections of the median raphe nucleus in the rat
Vertes, R. P., Fortin, W. J., & Crane, A. M. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19990517)407:4<555::aid-cne7>3.0.co;2-e · Cited by 552
Brezun, J. M., & Daszuta, A. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00693-9 · Cited by 549
O'Hearn, E., Battaglia, G., De Souza, E., Kuhar, M., & Molliver, M. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02788.1988 · Cited by 542
Jakab, R. L., & Goldman-Rakic, P. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.735 · Cited by 536
Meltzer, M. D. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00194-2 · Cited by 517
Donepezil for dementia due to Alzheimer's disease
Birks, J., & Harvey, R. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001190 · Cited by 515
Olabarria, M., Noristani, H. N., Verkhratsky, A., & Rodríguez, J. J. (2010) · Glia · doi:10.1002/glia.20967 · Cited by 499
Self-citationAzmitia, E. C. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00614-1 · Cited by 497 · cited 6×
“The density of 5-HT projections can also be regulated by brain derived neurotrophic factor (BDNF) and by 5- HT itself (Azmitia, 2001; Mamounas et al., 2000).”
InfluentialSantana, N. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh070 · Cited by 486
Meneses, A. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(99)00067-6 · Cited by 475
Astrocytes in Alzheimer's Disease
Verkhratsky, A., Olabarria, M., Noristani, H. N., Yeh, C.-Y., & Rodriguez, J. J. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.017 · Cited by 455
Self-citationChan, J., Aoki, C., & Pickel, V. M. (1990) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(90)90015-8 · Cited by 446
The neuropathology of aminergic nuclei in Alzheimer's disease
Zweig, R. M., Ross, C. A., Hedreen, J. C., Steele, C., Cardillo, J. E., Whitehouse, P. J., Folstein, M. F., & Price, D. L. (1988) · Annals of Neurology · doi:10.1002/ana.410240210 · Cited by 446
Bowen, D. M., Allen, S. J., Benton, J. S., Goodhardt, M. J., Haan, E. A., Palmer, A. M., Sims, N. R., Smith, C. C. T., Spillane, J. A., Esiri, M. M., et al. (1983) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1983.tb11838.x · Cited by 443
Cortical Change in Alzheimer's Disease Detected with a Disease-specific Population-based Brain Atlas
Thompson, P. M., Mega, M. S., Woods, R. P., Zoumalan, C. I., Lindshield, C. J., Blanton, R. E., Moussai, J., Holmes, C. J., Cummings, J. L., & Toga, A. W. (2001) · Cerebral Cortex · doi:10.1093/cercor/11.1.1 · Cited by 443
Role of serotonin in memory impairment.
Buhot, M.-C., Martin, S., & Segu, L. (2000) · Annals of Medicine · doi:10.3109/07853890008998828 · Cited by 419
Kosofsky, B. E., & Molliver, M. E. (1987) · Synapse · doi:10.1002/syn.890010204 · Cited by 412
Lyketsos, C. G., DelCampo, L., Steinberg, M., Miles, Q., Steele, C. D., Munro, C., Baker, A. S., Sheppard, J.-M. E., Frangakis, C., Brandt, J., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.737 · Cited by 398
Astroglia in dementia and Alzheimer's disease
Rodríguez, J. J., Olabarria, M., Chvatal, A., & Verkhratsky, A. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.172 · Cited by 397
Self-citationGrudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396
Sarnyai, Z., Sibille, E. L., Pavlides, C., Fenster, R. J., McEwen, B. S., & Tóth, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14731 · Cited by 396
Depression in Alzheimer’s disease: overview and treatment
Lyketsos, C. G., & Olin, J. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01348-3 · Cited by 394
Nyth, A. L., & Gottfries, C. G. (1990) · British Journal of Psychiatry · doi:10.1192/bjp.157.6.894 · Cited by 379
Cirrito, J. R., Disabato, B. M., Restivo, J. L., Verges, D. K., Goebel, W. D., Sathyan, A., Hayreh, D., D'Angelo, G., Benzinger, T., Yoon, H., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1107411108 · Cited by 377
Rodríguez, J. J., Jones, V. C., Tabuchi, M., Allan, S. M., Knight, E. M., LaFerla, F. M., Oddo, S., & Verkhratsky, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002935 · Cited by 377
Self-citationCholinergic nucleus basalis tauopathy emerges early in the aging‐MCI‐AD continuum
Mesulam, M., Shaw, P., Mash, D., & Weintraub, S. (2004) · Annals of Neurology · doi:10.1002/ana.20100 · Cited by 374
Aghajanian, G. K., & Marek, G. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01224-x · Cited by 374
Jones, B. E., & Cuello, A. C. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90029-8 · Cited by 369
8-Hydroxy-2-(dipropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist
Arvidsson, L. E., Hacksell, U., Nilsson, J. L. G., Hjorth, S., Carlsson, A., Lindberg, P., Sanchez, D., & Wikstroem, H. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00140a002 · Cited by 367
Changes in Cognitive Functioning Following Treatment of Late-Life Depression
Butters, M. A., Becker, J. T., Nebes, R. D., Zmuda, M. D., Mulsant, B. H., Pollock, B. G., & Reynolds, C. F. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1949 · Cited by 365
Morales, M., & Bloom, F. E. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-09-03157.1997 · Cited by 361
The effect of age on the activity and molecular properties of human brain monoamine oxidase
Fowler, C. J., Wiberg, �., Oreland, L., Marcusson, J., & Winblad, B. (1980) · Journal of Neural Transmission · doi:10.1007/bf01249185 · Cited by 348
Serotonergic Neuronal Systems: What Their Anatomic Organization Tells Us about Function
MOLLIVER, M. E. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198712001-00002 · Cited by 347
Serotonin 5-HT2A receptors are expressed on pyramidal cells and interneurons in the rat cortex
Willins, D. L., Deutch, A. Y., & Roth, B. L. (1997) · Synapse · doi:10.1002/(sici)1098-2396(199709)27:1<79::aid-syn8>3.0.co;2-a · Cited by 345
Mamounas, L. A., Altar, C. A., Blue, M. E., Kaplan, D. R., Tessarollo, L., & Lyons, W. E. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-02-00771.2000 · Cited by 344
Nucleus raphe dorsalis in Alzheimer's disease: Neurofibrillary tangles and loss of large neurons
Yamamoto, T., & Hirano, A. (1985) · Annals of Neurology · doi:10.1002/ana.410170608 · Cited by 338
Pollock, B. G., Mulsant, B. H., Rosen, J., Sweet, R. A., Mazumdar, S., Bharucha, A., Marin, R., Jacob, N. J., Huber, K. A., Kastango, K. B., et al. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.3.460 · Cited by 327
The dysregulation of intracellular calcium in Alzheimer disease
Supnet, C., & Bezprozvanny, I. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.014 · Cited by 323
Serotonergic modulation of the limbic system
Hensler, J. G. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.06.007 · Cited by 319
Whitaker-Azmitia, P. M., Murphy, R., & Azmitia, E. C. (1990) · Brain Research · doi:10.1016/0006-8993(90)90210-3 · Cited by 319
The Physiological Role of 5-HT2AReceptors in Working Memory
Williams, G. V., Rao, S. G., & Goldman-Rakic, P. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-07-02843.2002 · Cited by 311
Jacobs, B. L., & Fornal, C. A. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80141-9 · Cited by 311
Parsey, R. V., Oquendo, M. A., Simpson, N. R., Ogden, R. T., Van Heertum, R., Arango, V., & Mann, J. J. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03243-2 · Cited by 311
CROW, T. (1984) · Neuropharmacology · doi:10.1016/0028-3908(84)90100-x · Cited by 308
Serotonin receptors in cognitive behaviors
Buhot, M.-C. (1997) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(97)80013-x · Cited by 307
Ishii, T. (1966) · Acta Neuropathologica · doi:10.1007/bf00686763 · Cited by 303
Neuroglia in neurodegeneration
Heneka, M. T., Rodríguez, J. J., & Verkhratsky, A. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.11.004 · Cited by 301
Self-citationNeurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease
Xu, Y., Yan, J., Zhou, P., Li, J., Gao, H., Xia, Y., & Wang, Q. (2012) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2012.02.002 · Cited by 301
Age-dependent sexual dimorphism in cognition and stress response in the 3xTg-AD mice
Clinton, L. K., Billings, L. M., Green, K. N., Caccamo, A., Ngo, J., Oddo, S., McGaugh, J. L., & LaFerla, F. M. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.06.013 · Cited by 299
DRUGS WHICH ANTAGONIZE 5‐HYDROXYTRYPTAMINE
GADDUM, J. H., & HAMEED, K. A. (1954) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1954.tb00848.x · Cited by 293
Towards defining the neuropathological substrates of vascular dementia
Kalaria, R. N., Kenny, R. A., Ballard, C. G., Perry, R., Ince, P., & Polvikoski, T. (2004) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2004.09.019 · Cited by 291
SERUM VASOCONSTRICTOR (SEROTONIN)
Rapport, M. M. (1949) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)51208-x · Cited by 288
Mazer, C., Muneyyirci, J., Taheny, K., Raio, N., Borella, A., & Whitaker-Azmitia, P. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00297-7 · Cited by 287
The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour
Steckler, T., & Sahgal, A. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(94)00157-b · Cited by 281
Memory deficits associated with recreational use of "ecstasy" (MDMA)
Morgan, M. J. (1999) · Psychopharmacology · doi:10.1007/s002130050803 · Cited by 281
Mathews, T. A., Fedele, D. E., Coppelli, F. M., Avila, A. M., Murphy, D. L., & Andrews, A. M. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.05.017 · Cited by 276
Semba, K., Reiner, P. B., McGeer, E. G., & Fibiger, H. C. (1988) · Journal of Comparative Neurology · doi:10.1002/cne.902670311 · Cited by 276
Tryptophan depletion in normal volunteers produces selective impairment in memory consolidation.
Riedel, W. J., Klaassen, T., Deutz, N. E. P., van Someren, A., & van Praag, H. M. (1999) · Psychopharmacology · doi:10.1007/s002130050845 · Cited by 271
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1–40)
Miguel-Hidalgo, J. J., Alvarez, X. A., Cacabelos, R., & Quack, G. (2002) · Brain Research · doi:10.1016/s0006-8993(02)03731-9 · Cited by 265
Nyth, A. L., Gottfries, C. G., Lyby, K., Smedegaard‐Andersen, L., Gylding‐Sabroe, J., Kristensen, M., Refsum, H. ‐., Öfsti, E., Eriksson, S., & Syversen, S. (1992) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1992.tb03242.x · Cited by 258
Cassel, J.-C., & Jeltsch, H. (1995) · Neuroscience · doi:10.1016/0306-4522(95)00241-a · Cited by 256
5-HT6 Receptor Antagonists as Novel Cognitive Enhancing Agents for Alzheimer's Disease
Upton, N., Chuang, T. T., Hunter, A. J., & Virley, D. J. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.008 · Cited by 255
Bryant, J., Clegg, A., Nicholson, T., McIntyre, L., De Broe, S., Gerard, K., & Waugh, N. (2001) · Health Technology Assessment · doi:10.3310/hta5010 · Cited by 246
Dawson, L. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(01)00265-2 · Cited by 245
Garcia-Alloza, M., Gil-Bea, F. J., Diez-Ariza, M., Chen, C. P. L.-H., Francis, P. T., Lasheras, B., & Ramirez, M. J. (2005) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2004.06.007 · Cited by 244
Patterns of aberrant sprouting in alzheimer's disease
Masliah, E., Mallory, M., Hansen, L., Alford, M., Albright, T., DeTeresa, R., Terry, R., Baudier, J., & Saitoh, T. (1991) · Neuron · doi:10.1016/0896-6273(91)90170-5 · Cited by 244
Brezun, J. M., & Daszuta, A. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00932.x · Cited by 243
Serotonin 1A receptors in the living brain of Alzheimer's disease patients
Kepe, V., Barrio, J. R., Huang, S.-C., Ercoli, L., Siddarth, P., Shoghi-Jadid, K., Cole, G. M., Satyamurthy, N., Cummings, J. L., Small, G. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510237103 · Cited by 241
Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis
Lyness, S. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00057-x · Cited by 240
Hajszan, T., MacLusky, N. J., & Leranth, C. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.03968.x · Cited by 239
Hirst, W. D., Stean, T. O., Rogers, D. C., Sunter, D., Pugh, P., Moss, S. F., Bromidge, S. M., Riley, G., Smith, D. R., Bartlett, S., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.049 · Cited by 234
Dogrul, A., Ossipov, M. H., & Porreca, F. (2009) · Brain Research · doi:10.1016/j.brainres.2009.05.001 · Cited by 234
Handbook of the Behavioral Neurobiology of Serotonin
(2010) · Handbook of Behavioral Neuroscience · doi:10.1016/c2009-0-01827-3 · Cited by 233
Geldmacher, D. S., & Whitehouse, P. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608013350507 · Cited by 233
S-100B but not NGF, EGF, insulin or calmodulin is a CNS serotonergic growth factor
Azmitia, E. C., Dolan, K., & Whitaker-Azmitia, P. M. (1990) · Brain Research · doi:10.1016/0006-8993(90)90942-5 · Cited by 230
The Serotonin1A A Receptor: A Representative Member of the Serotonin Receptor Family
Pucadyil, T. J., Kalipatnapu, S., & Chattopadhyay, A. (2005) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-005-3969-3 · Cited by 229
Takeda, A., Loveman, E., Clegg, A., Kirby, J., Picot, J., Payne, E., & Green, C. (2006) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1402 · Cited by 227
Schmitt, J. A. J., Jorissen, B. L., Sobczak, S., van Boxtel, M. P. J., Hogervorst, E., Deutz, N. E. P., & Riedel, W. J. (2000) · Journal of Psychopharmacology · doi:10.1177/026988110001400102 · Cited by 227
Incidence of Dementia, Alzheimer's Disease, and Vascular Dementia in Italy. The ILSA Study
Di Carlo, A., Baldereschi, M., Amaducci, L., Lepore, V., Bracco, L., Maggi, S., Bonaiuto, S., Perissinotto, E., Scarlato, G., Farchi, G., et al. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50006.x · Cited by 225
CURCIO, C. A., & KEMPER, T. (1984) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-198407000-00001 · Cited by 225
SERUM VASOCONSTRICTOR (SEROTONIN)
Rapport, M. M., Green, A. A., & Page, I. H. (1948) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)57136-2 · Cited by 225
Marek, G. J., & Aghajanian, G. K. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00945-5 · Cited by 221
Rahman, S., Nestor, P. J., Hodges, J. R., Sahakian, B. J., & Deakin, J. B. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1686-5 · Cited by 221
Serotonin 5-HT2a and 5-HT2c Receptors Stimulate Amyloid Precursor Protein Ectodomain Secretion
Nitsch, R. M., Deng, M., Growdon, J. H., & Wurtman, R. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.8.4188 · Cited by 219 · cited 3×
“Abbreviations: [11C]-WAY100635, N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide; 3xTg-AD, triple transgenic mouse model of AD; 5,7-DHT, 5,7-dihydroxytryptamine; 5-HIAA, 5-hydroxyindoleacetic acid; 5-HT, 5-hydroxytrptamine (serotonin); 5HTR, 5-hydroxytrptamine receptor (serotonin rece…”
Cholinergic systems in the rat brain: IV. descending projections of the pontomesencephalic tegmentum
Woolf, N. J., & Butcher, L. L. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90197-4 · Cited by 219
Staubli, U., & Xu, F. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-03-02445.1995 · Cited by 217
Presynaptic Serotonergic Dysfunction in Patients with Alzheimer's Disease
Palmer, A. M., Francis, P. T., Benton, J. S., Sims, N. R., Mann, D. M. A., Neary, D., Snowden, J. S., & Bowen, D. M. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb13120.x · Cited by 214
Lyketsos, C. G., Sheppard, J.-M. E., Steele, C. D., Kopunek, S., Steinberg, M., Baker, A. S., Brandt, J., & Rabins, P. V. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.10.1686 · Cited by 214
The dorsal raphe nucleus—From silver stainings to a role in depression
Michelsen, K. A., Schmitz, C., & Steinbusch, H. W. M. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.01.002 · Cited by 213
Brainstem afferents to the basal forebrain in the rat
Vertes, R. P. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90077-2 · Cited by 208
Liu, Y., Yoo, M.-J., Savonenko, A., Stirling, W., Price, D. L., Borchelt, D. R., Mamounas, L., Lyons, W. E., Blue, M. E., & Lee, M. K. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4218-08.2008 · Cited by 206 · cited 6×
“Conversely, in AbPPswe/PS1DE9 transgenic mice and canine model of AD with Ab pathology, a decrease in 5-HT neuronal aggregates was reported in the dorsal and median raphe nuclei (Bernedo et al., 2009; Liu et al., 2008).”
InfluentialA role for 5-ht6 receptors in retention of spatial learning in the Morris water maze
Woolley, M. L., Bentley, J. C., Sleight, A. J., Marsden, C. A., & Fone, K. C. F. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00056-9 · Cited by 206
Alzheimer's disease: Neurofibrillary tangles in nuclei that project to the cerebral cortex
German, D. C., White, C. L., & Sparkman, D. R. (1987) · Neuroscience · doi:10.1016/0306-4522(87)90123-0 · Cited by 203
Dillon, K. A., Gross-Isseroff, R., Israeli, M., & Biegon, A. (1991) · Brain Research · doi:10.1016/0006-8993(91)90171-q · Cited by 198
Jansen, K. L. R., Faull, R. L. M., Dragunow, M., & Synek, B. L. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90246-z · Cited by 198
Role of the Serotonin 5-HT2AReceptor in Learning
Harvey, J. A. (2003) · Learning & Memory · doi:10.1101/lm.60803 · Cited by 197
MICHELSEN, K., PRICKAERTS, J., & STEINBUSCH, H. (2008) · Progress in Brain Research · doi:10.1016/s0079-6123(08)00912-6 · Cited by 196
An integrative hypothesis concerning the pathogenesis and progression of Alzheimer's disease
Hardy, J. A., Mann, D. M. A., Wester, P., & Winblad, B. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90086-2 · Cited by 196
Serotonin Receptor Changes in Dementia of the Alzheimer Type
Cross, A. J., Crow, T. J., Ferrier, I. N., Johnson, J. A., Bloom, S. R., & Corsellis, J. A. N. (1984) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1984.tb06081.x · Cited by 195
The Pathogenesis of Alzheimers Disease—Is It a Lifelong “Calciumopathy”?
Stutzmann, G. E. (2007) · The Neuroscientist · doi:10.1177/1073858407299730 · Cited by 195
Senut, M. C., Menetrey, D., & Lamour, Y. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90260-1 · Cited by 194
Dringenberg, H. C. (2000) · Behavioural Brain Research · doi:10.1016/s0166-4328(00)00261-8 · Cited by 191
Köhler, C., Chan‐Palay, V., & Steinbusch, H. (1982) · Journal of Comparative Neurology · doi:10.1002/cne.902090109 · Cited by 188
Roth, M., Mountjoy, C. Q., Amrein, R., & The International Collaborative Study Group (1996) · British Journal of Psychiatry · doi:10.1192/bjp.168.2.149 · Cited by 188
Phinney, A. L., Deller, T., Stalder, M., Calhoun, M. E., Frotscher, M., Sommer, B., Staufenbiel, M., & Jucker, M. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-19-08552.1999 · Cited by 187
Jones, B. E. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.902950311 · Cited by 185
Reynolds, G. P., Mason, S. L., Meldrum, A., De Keczer, S., Parties, H., Eglen, R. M., & Wong, E. H. F. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb13303.x · Cited by 180
Pirker, W., Asenbaum, S., Hauk, M., Kandlhofer, S., Tauscher, J. T., Willeit, M., Neumeister, A., Praschak-Rieder, N., Angelberger, P., & Brücke, T. (2000) · PubMed · Cited by 180
Monoamine neurons in aging and Alzheimer's disease
Palmer, A. M., & DeKosky, S. T. (1993) · Journal of Neural Transmission · doi:10.1007/bf01245229 · Cited by 178
(1996) · The Journal of Neuropsychiatry and Clinical Neurosciences · doi:10.1176/jnp.8.3.270 · Cited by 176
Dendritic sprouting in Alzheimer's presenile dementia
Scheibel, A. B., & Tomiyasu, U. (1978) · Experimental Neurology · doi:10.1016/0014-4886(78)90164-4 · Cited by 176
Cytoarchitecture of the human dorsal raphe nucleus
Baker, K. G., Halliday, G. M., & Törk, I. (1990) · Journal of Comparative Neurology · doi:10.1002/cne.903010202 · Cited by 174
5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex
Consolo, S., Arnaboldi, S., Giorgi, S., Russi, G., & Ladinsky, H. (1994) · NeuroReport · doi:10.1097/00001756-199406020-00018 · Cited by 174
NELSON, R., GUO, Z., HALAGAPPA, V, PEARSON, M., GRAY, A., MATSUOKA, Y., BROWN, M., MARTIN, B., IYUN, T., & MAUDSLEY, S. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.01.037 · Cited by 173
Lai, M. K. P., Tsang, S. W. Y., Francis, P. T., Esiri, M. M., Keene, J., Hope, T., & Chen, C. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02554-x · Cited by 173
Blin, J., Baron, J. C., Dubois, B., Crouzel, C., Fiorelli, M., Attar-Lévy, D., Pillon, B., Fournier, D., Vidailhet, M., & Agid, Y. (1993) · Brain · doi:10.1093/brain/116.3.497 · Cited by 172
Nilsson, O. G., Strecker, R. E., Daszuta, A., & Björklund, A. (1988) · Brain Research · doi:10.1016/0006-8993(88)90163-1 · Cited by 170
Götz, J., Schild, A., Hoerndli, F. J., & Pennanen, L. (2004) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2004.07.013 · Cited by 167
In Vivo Excitation of GABA Interneurons in the Medial Prefrontal Cortex through 5-HT3 Receptors
Puig, M. V., Santana, N., Celada, P., Mengod, G., & Artigas, F. (2004) · Cerebral Cortex · doi:10.1093/cercor/bhh097 · Cited by 167
Glucose metabolism and serotonin receptors in the frontotemporal lobe degeneration
Franceschi, M., Anchisi, D., Pelati, O., Zuffi, M., Matarrese, M., Moresco, R. M., Fazio, F., & Perani, D. (2005) · Annals of Neurology · doi:10.1002/ana.20365 · Cited by 166
Steinbusch, H. W. M., Nieuwenhuys, R., Verhofstad, A. A. J., & Van der Kooy, D. (1981) · PubMed · Cited by 165
Zhuo, M., & Gebhart, G. F. (1991) · Brain Research · doi:10.1016/0006-8993(91)90402-h · Cited by 164
Finkel, S. I., Mintzer, J. E., Dysken, M. W., Krishnan, K., Burt, T., & McRae, T. D. (2004) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.998 · Cited by 163
PET Imaging of Serotonin Type 2A Receptors in Late-Life Neuropsychiatric Disorders
Meltzer, C. C., Price, J. C., Mathis, C. A., Greer, P. J., Cantwell, M. N., Houck, P. R., Mulsant, B. H., Ben-Eliezer, D., Lopresti, B., DeKosky, S. T., et al. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.12.1871 · Cited by 163
Taragano, F. E., Lyketsos, C. G., Mangone, C. A., Allegri, R. F., & Comesaña-Diaz, E. (1997) · Psychosomatics · doi:10.1016/s0033-3182(97)71461-0 · Cited by 162
Mice lacking 5‐HT7 receptors show specific impairments in contextual learning
Roberts, A. J., Krucker, T., Levy, C. L., Slanina, K. A., Sutcliffe, J. G., & Hedlund, P. B. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03288.x · Cited by 162
Neurogenesis in Alzheimer’s disease: Neurogenesis in AD
Rodríguez, J. J., & Verkhratsky, A. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01343.x · Cited by 161
Self-citationSenile plaques as aberrant sprout-stimulating structures
Geddes, J. W., Anderson, K. J., & Cotman, C. W. (1986) · Experimental Neurology · doi:10.1016/0014-4886(86)90254-2 · Cited by 161
Serotonergic mechanisms in brains of suicide victims
Owen, F., Chambers, D. R., Cooper, S. J., Crow, T. J., Johnson, J. A., Lofthouse, R., & Poulter, M. (1986) · Brain Research · doi:10.1016/0006-8993(86)91415-0 · Cited by 160
5-HT2 Receptor Regulation of Extracellular GABA Levels in the Prefrontal Cortex
Abi-Saab, W. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00046-3 · Cited by 158
Brayne, C., Gill, C., Huppert, F. A., Barkley, C., Gehlhaar, E., Girling, D. M., O’Connor, D., & Paykel, E. S. (1995) · The British Journal of Psychiatry · doi:10.1192/bjp.167.2.255 · Cited by 158
Wilson, M. A., Ricaurte, G. A., & Molliver, M. E. (1989) · Neuroscience · doi:10.1016/0306-4522(89)90237-6 · Cited by 156
5-HT 6 receptor antagonists enhance retention of a water maze task in the rat
Rogers, D., & Hagan, J. J. (2001) · Psychopharmacology · doi:10.1007/s002130100840 · Cited by 155
García-Alloza, M., Hirst, W. D., Chen, C., Lasheras, B., Francis, P. T., & Ramírez, M. J. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300330 · Cited by 154
Petracca, G., Chemerinski, E., & STARKSTEIN, S. E. (2001) · International Psychogeriatrics · doi:10.1017/s104161020100761x · Cited by 154
Carli, M., & SAMANIN, R. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09045.x · Cited by 150
Changes in monamines and their metabolite levels in some brain regions of aged rats
Ponzio, F., Calderini, G., Lomuscio, G., Vantini, G., Toffano, G., & Algeri, S. (1982) · Neurobiology of Aging · doi:10.1016/0197-4580(82)90057-4 · Cited by 150
Brezun, J., & Daszuta, A. (2000) · Hippocampus · doi:10.1002/(sici)1098-1063(2000)10:1<37::aid-hipo4>3.0.co;2-c · Cited by 150
The evolution of Alzheimer's disease‐related cytoskeletal pathology in the human raphe nuclei
Rüb, U., Tredici, K. D., Schultz, C., Thal, D. R., Braak, E., & Braak, H. (2000) · Neuropathology and Applied Neurobiology · doi:10.1046/j.0305-1846.2000.00291.x · Cited by 145
Magai, C., Kennedy, G., Cohen, C. I., & Gomberg, D. (2000) · The American Journal of Geriatric Psychiatry · doi:10.1097/00019442-200002000-00009 · Cited by 143
Marcusson, J. O., Morgan, D., Winblad, B. G., & Finch, C. E. (1984) · Brain Research · doi:10.1016/0006-8993(84)91397-0 · Cited by 143
Assal, F., Alarcón, M., Solomon, E., Masterman, D. L., Geschwind, D. H., & Cummings, J. L. (2004) · Archives of Neurology · doi:10.1001/archneur.61.8.1249 · Cited by 142
Meneses, A., & Perez-Garcia, G. (2007) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2007.02.001 · Cited by 141
Topographical distribution of neurochemical changes in Alzheimer's disease
PROCTER, A. W., Lowe, S. L., Palmer, A. M., Francis, P. T., Esiri, M. M., Stratmann, G. C., Najlerahim, A., Patel, A. J., Hunt, A., & Bowen, D. M. (1988) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(88)90118-9 · Cited by 139
Scruggs, J. L., Schmidt, D. E., & Deutch, A. Y. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00547-0 · Cited by 138
Richter‐Levin, G., & Segal, M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91437-6 · Cited by 138
Chen, C., Alder, J. T., Bowen, D. M., Esiri, M. M., McDonald, B., Hope, T., Jobst, K. A., & Francis, P. T. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.66041592.x · Cited by 136
The topography of cell loss from locus caeruleus in Alzheimer's disease
Marcyniuk, B., Mann, D. M. A., & Yates, P. O. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90179-6 · Cited by 135
Schechter, L. E., Smith, D. L., Rosenzweig-Lipson, S. J., Rizzo, S. J. S., Dawson, L. A., Marquis, K. L., Jones, D., Piesla, M. J., Andree, T. H., Nawoschik, S. P., et al. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.086363 · Cited by 135
Foley, A., Murphy, K. J., Hirst, W. D., Gallagher, H. C., Hagan, J. J., Upton, N., Walsh, F. S., & Regan, C. M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300332 · Cited by 133
MELTZER, C. C., Smith, G. S., Price, J. C., Reynolds, C. F., Mathis, C. A., Greer, P. J., Lopresti, B. J., Mintun, M. A., Pollock, B. G., Ben-Eliezer, D., et al. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00909-3 · Cited by 130
Serotonin 5-HT1A Receptor Binding Potential Declines with Age as Measured by [11C]WAY-100635 and PET
Tauscher, J. T. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00227-x · Cited by 130
Brorson, J. R., Bindokas, V. P., Iwama, T., Marcuccilli, C. J., Chisholm, J. C., & Miller, R. J. (1995) · Journal of Neurobiology · doi:10.1002/neu.480260305 · Cited by 129
Reduced 5-HT2A receptor binding in patients with mild cognitive impairment
Hasselbalch, S. G., Madsen, K., Svarer, C., Pinborg, L. H., Holm, S., Paulson, O. B., Waldemar, G., & Knudsen, G. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.04.011 · Cited by 129
de Almeida, J., & Mengod, G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04768.x · Cited by 129
Terry, A. V., Buccafusco, J. J., & Wilson, C. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.12.006 · Cited by 126
The 5-HT7 receptor is involved in allocentric spatial memory information processing
Sarkisyan, G., & Hedlund, P. B. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.011 · Cited by 125
Lai, M. K. P., Tsang, S. W., Alder, J. T., Keene, J., Hope, T., Esiri, M. M., Francis, P. T., & Chen, C. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2077-2 · Cited by 125
The selectivity of the reduction of serotonin S2 receptors in Alzheimer-type dementia
Cross, A. J., Crow, T. J., Ferrier, I. N., & Johnson, J. A. (1986) · Neurobiology of Aging · doi:10.1016/0197-4580(86)90019-9 · Cited by 123
Hendricksen, M., Thomas, A. J., Ferrier, I. N., Ince, P., & O’Brien, J. T. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.6.1096 · Cited by 121
Cho, S., & Hu, Y. F. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.07.021 · Cited by 120
Age-related decline in central serotonin transporter availability with [123I]β-CIT SPECT
van Dyck, C. H., Malison, R. T., Seibyl, J. P., Laruelle, M. A., Klumpp, H., Zoghbi, S. S., Baldwin, R. M., & Innis, R. B. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00152-4 · Cited by 119
Cited by
A review on Alzheimer's disease pathophysiology and its management: an update
Kumar, A., Singh, A., & Ekavali (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2014.09.004 · Cited by 1,578
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Loh, J. S., Mak, W. Q., Tan, L. K. S., Ng, C. X., Chan, H. H., Yeow, S. H., Foo, J. B., Ong, Y. S., How, C. W., & Khaw, K. Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01743-1 · Cited by 1,193
Therapeutics of Alzheimer's disease: Past, present and future
Anand, R., Gill, K. D., & Mahdi, A. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.07.004 · Cited by 747
Rajmohan, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160612 · Cited by 688
Trushina, E., Dutta, T., Persson, X.-M. T., Mielke, M. M., & Petersen, R. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063644 · Cited by 438
“with subsequent loss of associated neurons [42].”
Background
Metadata
- Authors
- Rodríguez, J. J., Noristani, H. N., & Verkhratsky, A.
- Venue
- Progress in Neurobiology
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 99
- Issue
- 1
- Pages
- 15-41
- ISSN
- 0301-0082 (ISSN-L)
- OpenAlex
- W2029821777
- Cited by
- 264
- References
- 469
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.